Videos - Breast Cancer

How would you rate this content? Submit Rating

Professor Hilary Martin discusses HR+ and HER2- metastatic breast cancer

Join Dr. Nick Zdenkowski for an insightful commentary on breast cancer therapeutics. He will cover the latest clinical trial results and emerging therapies, including CDK4/6 inhibitors, antibody-drug conjugates (ADCs), endocrine therapy, and PARP inhibitors. Dr. Zdenkowski will discuss the mechanisms of action, efficacy, and safety profiles of these treatments.

COMING SOON! Video highlights from the American Society of Clinical Oncology (ASCO) 2025, taking place in Chicago, IL from May 30 - June 3, 2025. These clips will provide invaluable insights and updates on Breast Cancer research from ASCO 2025.

Dr. Danusha Sabanathan gives a comprehensive overview of pain management, emphasizing the importance of a multidisciplinary approach, shared decision-making, patient education, and addressing barriers to accessing pain management resources.

Dr. Nick Zdenkowski discusses a case of early-stage, high-risk breast cancer, detailing the patient's diagnosis, treatment plan, and outcomes.

Dr. Nick Zdenkowski discusses tumor-infiltrating lymphocytes as prognostic and predictive factors in breast cancer.

Dr. Virginia Kaklamani discusses the PATINA trial, a phase III clinical trial.

Dr. Nick Zdenkowski discusses resistance mechanisms to CDK4/6 inhibitors.

Dr. Virginia Kaklamani highlights the EMBER-3 clinical trial, which found that imlunestrant outperformed single-agent endocrine therapy in patients with ESR1 mutations and showed improvement when combined with abemaciclib, suggesting potential FDA approval.

Dr. Nick Zdenkowski discusses the ZEST trial.

Dr. Carlos Barrios discusses the PATINA trial that was presented recently.

Dr. Nick Zdenkowski discusses the SUPREMO trial.

Dr. Nick Zdenkowski discusses the PATINA trial.

Dr. Sherene Loi discusses the development and importance of immune biomarkers in breast cancer, highlighting the TIL biomarker, the limitations of PD-L1, and the potential of new biomarkers to refine treatment algorithms and clinical trials

Dr. Nick Zdenkowski discusses the EMBER trial on second-line ER-targeted drugs, patient-reported outcome monitoring, and the survival benefits of risk-reducing surgeries for BRCA mutant patients.

Dr. Nicholas Zdenkowski informs us that the authors presented their priorities in breast cancer, focusing on shared decision-making, optimizing multidisciplinary consultation, and improving data on metastatic breast cancer to better care for these patients.

Video highlights from the San Antonio Breast Cancer Symposium (SABCS) 2024, taking place in San Antonio, TX from December 10 to 13, 2024.

Dr. Dhanusha Sabanathan, a medical oncologist from Sydney, presents cases of metastatic breast cancer, highlighting the effectiveness of the latest medications in treating metaplastic triple-negative breast cancer with minimal side effects.

Video highlights from the European Society for Medical Oncology (ESMO) Conference 2024, taking place in Barcelona from September 13 to September 17. These clips will provide invaluable insights and updates on Breast Cancer research from ESMO 2024. Stay tuned for more details and expert presentations!

• Latest research highlights from the American Society of Clinical Oncology Annual Meeting 2024
• Exclusive insights provided by our esteemed experts Dr. Roland CY Leung, Dr. Chun-Yu Liu, Prof. Sherene Loi, Prof. Nick Zdenkowski and Dr. Dhanusha Sabanathan
• Explore these highlights to enhance your clinical practice and stay updated on the latest advancements

• Latest research highlights from the 2023 edition of the San Antonio Breast Cancer Symposium
• Exclusive insights provided by our esteemed experts Dr. Roland CY Leung, Dr. Chun-Yu Liu, Prof. Sherene Loi, Prof. Bruce Mann and Prof. Nick Zdenkowski
• Explore these highlights to enhance your clinical practice and stay updated on the latest advancements

• Overview of the prevalence and clinical landscape of Breast Cancer (BC), with a focused mention of the Asia Pacific region • Overview of the subtypes and risk factors associated with BC, the predictive models of assessing the risk of developing BC as well as diagnostic approaches and major treatment strategies of BC • Also emphasizes the need and means of early detection of BC for better clinical outcomes